Rose Pharma Inc
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Effect of GLP-1 Analogue ROSE-010 on Appetite in Overweight and Obese Subjects (NCT06621017) | Rose Pharma Inc | 2024-09-26 |
Track Rose Pharma Inc automatically
Every clearance here is in the API, with alerts when new ones post.